27 Oct 2011 10:21
e-Therapeutics plc ("e-Therapeutics" or the "Company")
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
e-Therapeutics (AIM: ETX), the drug discovery and development company, announces the following Director's Market Share Purchase.
On 25 October 2011 Prof. Oliver James, Non-executive Chairman, purchased 25,000 ordinary shares at 29.85p per share. His resultant total holding is 63,500 shares, representing 0.05% of the issued share capital of the Company, which currently stands at 138,126,467 shares all carrying voting rights.
27 October 2011.
For more information, please contact:
e-Therapeutics plc
Malcolm Young
Tel: +44 (0) 191 233 1317
E-mail: malcolm@etherapeutics.co.uk
www.etherapeutics.co.uk
Panmure Gordon (UK) Limited
Andrew Burnett / Aubrey Powell
Tel: +44 (0) 20 7459 3600
www.panmure.com
ETX.L (ETX)